A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Glutamic Acid Decarboxylase
MessageSendout, Mayo test code: GD65S
Test Code
LAB650
Alias/See Also
64K Antibody
Anti-GAD Antibodies
Anti-Glutamic Acid Decarboxylase Ab
Beta Cell Antibody
GAD65 Antibody Assay
Glutamate Decarboxylase Antibodies (GAD65)
Islet cell antibody
Pancreatic Islet Cell Ab
Stiffman Syndrome
Stiff person
Ataxia
GD65S
Anti-GAD Antibodies
Anti-Glutamic Acid Decarboxylase Ab
Beta Cell Antibody
GAD65 Antibody Assay
Glutamate Decarboxylase Antibodies (GAD65)
Islet cell antibody
Pancreatic Islet Cell Ab
Stiffman Syndrome
Stiff person
Ataxia
GD65S
CPT Codes
86341
Preferred Specimen
1.5 mL serum from a gold serum gel tube
Minimum Volume
1 mL
Other Acceptable Specimens
Red tube
Instructions
Centrifuge and aliquot serum into a plastic vial.
Transport Container
Plastic vial
Transport Temperature
Refrigerated
Specimen Stability
Refrigerated (preferred): 28 days
Frozen: 28 days
Ambient: 72 hours
Frozen: 28 days
Ambient: 72 hours
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis: Mild OK; Gross reject
Lipemia: Mild OK; Gross reject
Icterus: Mild OK; Gross reject
Lipemia: Mild OK; Gross reject
Icterus: Mild OK; Gross reject
Methodology
Radioimmunoassay (RIA)
FDA Status
Approved
Setup Schedule
Monday through Sunday
Report Available
3-6 days
Limitations
Antibodies specific for glutamic acid decarboxylase (GAD65) account for most, but not all, antibodies detected in the islet cell antibody test (IA-2). IA-2 (a protein tyrosine kinase-like protein), insulin, and zinc transporter-8 antibodies are complementary islet cell antibodies.
Reference Range
Included with report
Clinical Significance
Assessing susceptibility to autoimmune (type 1, insulin-dependent) diabetes mellitus and related endocrine disorders (eg, thyroiditis and pernicious anemia).
Distinguishing between patients with type 1 and type 2 diabetes.
Confirming a diagnosis of stiff-man syndrome, autoimmune encephalitis, autoimmune ataxia, brain stem encephalitis, autoimmune epilepsy, autoimmune myelopathy.
Distinguishing between patients with type 1 and type 2 diabetes.
Confirming a diagnosis of stiff-man syndrome, autoimmune encephalitis, autoimmune ataxia, brain stem encephalitis, autoimmune epilepsy, autoimmune myelopathy.
Performing Laboratory
Mayo Clinic Laboratories, Rochester, Minnesota
Additional Information
Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Serum